Colin Watts

12.8k total citations · 2 hit papers
110 papers, 4.8k citations indexed

About

Colin Watts is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Colin Watts has authored 110 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Genetics, 22 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Colin Watts's work include Glioma Diagnosis and Treatment (74 papers), Meningioma and schwannoma management (15 papers) and Brain Metastases and Treatment (11 papers). Colin Watts is often cited by papers focused on Glioma Diagnosis and Treatment (74 papers), Meningioma and schwannoma management (15 papers) and Brain Metastases and Treatment (11 papers). Colin Watts collaborates with scholars based in United Kingdom, United States and Netherlands. Colin Watts's co-authors include Sara Piccirillo, Inmaculada Spiteri, Andrea Sottoriva, Christina Curtis, Simon Tavaré, Anestis Touloumis, John C. Marioni, V. Peter Collins, Anthony J. Chalmers and Dieta Brandsma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Colin Watts

105 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

2013 1.2k citations Andrea Sottoriva, Inmaculada Spiteri et al. Proceedings of the National Academy of Sciences profile →
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

2017 426 citations Dieta Brandsma, Colin Watts et al. profile →

Peers

Countries citing papers authored by Colin Watts

Since Specialization

Citations

This map shows the geographic impact of Colin Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Watts more than expected).

Fields of papers citing papers by Colin Watts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Watts. The network helps show where Colin Watts may publish in the future.

Co-authorship network of co-authors of Colin Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Watts. A scholar is included among the top collaborators of Colin Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Watts. Colin Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Well-being and coping: Key aspects of unmet need of people living with glioma	Neuro-Oncology Practice	Stephanie Sivell, Ameeta Retzer et al.	0
2	Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial	Neuro-Oncology Practice	Michael D. Jenkinson, Helen Bulbeck et al.	0
3	P18.39.A SEIZURE PROPHYLAXIS IN GLIOMA SURGERY (SPRING): A MULTI-CENTRE, UNBLINDED, RANDOMISED TRIAL	Neuro-Oncology	Michael D. Jenkinson, Helen Bulbeck et al.	2
4	Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies	Neuro-Oncology Advances	Anna Giczewska, Aslι Küçükosmanoğlu et al.	8
5	Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study	Neuro-Oncology Advances	Ameeta Retzer, Stephanie Sivell et al.	4
6	Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?	British Journal of Neurosurgery	Charles H. Davis, Rohitashwa Sinha et al.	8
7	Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study	BMJ Open	Ameeta Retzer, Stephanie Sivell et al.	7
8	Protocol for the Tessa Jowell BRAIN MATRIX Platform Study	BMJ Open	Colin Watts, Joshua Savage et al.	4
9	FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial	BMJ Open	Puneet Plaha, Sophie Camp et al.	12
10	Comparison of outcomes of neurosurgical operations performed before and during the COVID-19 pandemic: a matched cohort study	BMJ Open	Emma Toman, Wai Cheong Soon et al.	5
11	Spatial heterogeneity of cell-matrix adhesive forces predicts human glioblastoma migration	Neuro-Oncology Advances	Bill Jia, Ivan B. Dimov et al.	12
12	Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance	Science Translational Medicine	Leila Akkari, Robert L. Bowman et al.	221
13	Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models	Cancer Research	Richard Mair, Florent Moulière et al.	68
14	Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma	Cancer Research	Richard Mair, Alan J. Wright et al.	33
15	ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)	Neuro-Oncology	Anthony J. Chalmers, Garth Cruickshank et al.	14
16	Irradiating the Subventricular Zone in Glioblastoma Patients: Is there a Case for a Clinical Trial?	Clinical Oncology	R. Jena, Colin Watts et al.	23
17	Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells	Cancer Research	Shafiq U. Ahmed, Ross Carruthers et al.	138
18	Contributions to Drug Resistance in Glioblastoma Derived from Malignant Cells in the Sub-Ependymal Zone	Cancer Research	Sara Piccirillo, Inmaculada Spiteri et al.	43
19	Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics breakdown →	Proceedings of the National Academy of Sciences	Andrea Sottoriva, Inmaculada Spiteri et al.	1231
20	Strategies to accelerate diagnosis of primary brain tumors at the primary–secondary care interface in children and adults	CNS Oncology	David Walker, William Hamilton et al.	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact